Morgan Stanley Maintains Equal-Weight on Incyte, Raises Price Target to $104
Incyte Corporation
Incyte Corporation INCY | 0.00 |
Morgan Stanley analyst Judah Frommer maintains Incyte (NASDAQ:
INCY) with a Equal-Weight and raises the price target from $103 to $104.